Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans

被引:9
作者
Emanuele, E
Peros, E
Tomaino, C
Feudatari, E
Bernardi, L
Binetti, G
Maletta, R
Micieli, G
Bruni, AC
Geroldi, D
机构
[1] Univ Pavia, Mol Med Lab, IRCCS, Policlin San Matteo, I-27100 Pavia, Italy
[2] Univ Pavia, IRCCS Casimiro Mondino, Dept Neurol, I-27100 Pavia, Italy
[3] Ctr San Giovanni di Dio, FBF, IRCCS, Memory Clin, Brescia, Italy
[4] Ctr San Giovanni di Dio, FBF, IRCCS, Neurobiol Lab, Brescia, Italy
[5] Reg Ctr Neurogenet, Lamezia Terme, CZ, Italy
[6] Univ Pavia, Policlin San Matteo, IRCCS, Dept Internal Med & Med Therapeut, I-27100 Pavia, Italy
关键词
apolipoprotein(a) isoforms; frontotemporal dementia; susceptibility; biomarkers;
D O I
10.1016/j.neulet.2003.09.046
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Apolipoprotein(a) [apo(a)] is a genetically polymorphic glycoprotein that has several similarities to apolipoprotein E. However, its role as a risk factor for frontotemporal dementia (FTD) remains to be elucidated. We therefore investigated the effect of an apo(a) polymorphism on the incidence of FTD in a sample of Caucasian Italian patients. From the entire group of FTD patients (n = 54), 55.6% of the subjects had at least one apo(a) low molecular weight (MW) isoform, compared to 29.9% of non-demented controls (n = 77). The difference between the two groups was statistically significant (odds ratio 2.93, 95% confidence interval 1.42-6.06, P = 0.003). The FTD group was further divided into sporadic (n = 26) and familial (n = 28) cases. Even after such dichotomization, both sporadic and familial FTD patients showed a significantly higher prevalence of low MW apo(a) isoforms than the cognitively healthy controls (P = 0.011 and P = 0.025, respectively). Our data suggest a role of apo(a) phenotypes of low MW in mediating susceptibility to FTD. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:201 / 204
页数:4
相关论文
共 23 条
[11]  
Kowalska A, 2002, FOLIA NEUROPATHOL, V40, P1
[12]   Apolipoprotein E ε2 may be a risk factor for sporadic frontotemporal dementia [J].
Lehmann, DJ ;
Smith, AD ;
Combrinck, M ;
Barnetson, L ;
Joachim, C .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (03) :404-405
[13]   IDENTIFICATION OF 34 APOLIPOPROTEIN(A) ISOFORMS - DIFFERENTIAL EXPRESSION OF APOLIPOPROTEIN(A) ALLELES BETWEEN AMERICAN BLACKS AND WHITES [J].
MARCOVINA, SM ;
ZHANG, ZH ;
GAUR, VP ;
ALBERS, JJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (03) :1192-1196
[14]   Astrocytes degenerate in frontotemporal dementia: possible relation to hypoperfusion [J].
Martin, JA ;
Craft, DK ;
Su, JH ;
Kim, RC ;
Cotman, CW .
NEUROBIOLOGY OF AGING, 2001, 22 (02) :195-207
[15]   A study of the Lund-Manchester research criteria for frontotemporal dementia: Clinical and single-photon emission CT correlations [J].
Miller, BL ;
Ikonte, C ;
Ponton, M ;
Levy, M ;
Boone, K ;
Darby, A ;
Berman, N ;
Mena, I ;
Cummings, JL .
NEUROLOGY, 1997, 48 (04) :937-942
[16]   FRONTAL-LOBE DEGENERATION - CLINICAL, NEUROPSYCHOLOGICAL, AND SPECT CHARACTERISTICS [J].
MILLER, BL ;
CUMMINGS, JL ;
VILLANUEVAMEYER, J ;
BOONE, K ;
MEHRINGER, CM ;
LESSER, IM ;
MENA, I .
NEUROLOGY, 1991, 41 (09) :1374-1382
[17]   Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease [J].
Mooser, V ;
Helbecque, N ;
Miklossy, J ;
Marcovina, SM ;
Nicod, P ;
Amouyel, P .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (07) :533-537
[18]   Bcl-2 family protein behavior in frontotemporal dementia implies vascular involvement [J].
Nichol, KE ;
Kim, R ;
Cotman, CW .
NEUROLOGY, 2001, 56 (11) :S35-S40
[19]  
Ramharack R, 1996, J LIPID RES, V37, P2029
[20]   Frontotemporal dementia [J].
Snowden, JS ;
Neary, D ;
Mann, DMA .
BRITISH JOURNAL OF PSYCHIATRY, 2002, 180 :140-143